Palliative Medicine
eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Share:
Share:
abstract:
Case report

Medication-related osteonecrosis of the jaw as a complication of palliative treatment of breast cancer

Katarzyna Janik
1
,
Daria Wziątek-Kuczmik
2
,
Zuzanna Galicka
1
,
Maciej Kamiński
2
,
Iwona Niedzielska
2

  1. Student Scientific Society at the Department of Cranio-Maxillofacial Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
  2. Department of Cranio-Maxillofacial Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
Medycyna Paliatywna 2025; 17(4)
Online publish date: 2025/11/05
View full text Get citation
 
PlumX metrics:
Medication-related osteonecrosis of the jaw (MRONJ) is a disease associated with the dysregulation of bone metabolism due to antiresorptive or antiangiogenic therapy. Any surgical interventions at such a stage should be performed under antibiotic cover. This report describes a case of a patient who underwent oral surgery without antibiotic cover, while receiving intravenous zoledronate treatment, which led to the development of MRONJ. Initially, her state corresponded to stage 2 of the disease. At that moment, the patient refused to continue the recommended surgical treatment. One year later she was referred to the clinic due to mobility of the mandible, which corresponded to stage 3 of MRONJ. A segmental resection of the mandible, followed by reconstruction using a titanium plate, was performed. This case highlights the importance of interdisciplinary collaboration between different specialists, as well as clear communication with the patient during the diagnostic process and treatment planning.
keywords:

bisphosphonate, breast cancer, osteonecrosis, zoledronic acid, MRONJ

Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.